Home / Respiratory system / Doxylamine, Combinations
ATC R06AA59 · Aminoalkyl Ethers
Doxylamine, Combinations shortage
As of 2 Nov 2026, Doxylamine, Combinations has a reported shortage in 3 of the 16 countries we track (Czechia, Norway, Sweden), covering 3 products from 3 companies.
Countries3/16
Products3packs or presentations
Companies30 listed
Short since25 Sep 202513 months ago
Earliest return23 Nov 2026company estimate
Main reasonCommercial decision or withdrawal
United StatesNo reported shortageCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechia1 product shortNorway1 product shortSweden1 product shortJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage
Timeline
CzechiaNorwaySweden
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group R06AA · Aminoalkyl EthersAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | XONVEA 10MG/10MG 10MG/10MG TBL ENT 20 | Exeltis Czech s.r.o., Praha | 25 Sep 2025 | 31 Oct 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| NO | Embagyn 20 mg/20 mg tablett med modifisert frisetting, 20 stk blisterpakning | Exeltis Healthcare S.L. (1) | 26 Oct 2026 | 19 Jan 2027 | Quality problem or recall Kvalitetsproblemer |
| SE | Bonjesta 20 mg/20 mg Blister, 20 tabletter | Exeltis Healthcare, S.L. | 17 Aug 2026 | 23 Nov 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.